JENNIFER L GOOD
CIK 1229245 · President & CEO · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.28M
Companies
4
Total Filings
49
Lifetime Open-Market Net
-$4.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | Director | 11,712 | $105.77 | $1.24M | -$4.27M | 13 | 2026-06-25 |
| TRVI | President & CEO | 218,576 | $18.50 | $4.04M | -$195.5K | 19 | 2026-02-20 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 2 | 2018-08-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | President & CEO | 18,034 | — | — | $16.1K | 10 | 2010-09-22 |
Recent Filings · Page 5 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-28 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Exer (M) | +25,000 | $39.0K | EDGAR |
| 2010-03-08 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-12 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Buy (P) | +7,500 | $16.1K | EDGAR |
| 2009-03-09 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-18 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-12 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-04-07 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-14 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-02 | PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–49 of 49
Prev
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.